Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan.
about
Lower extremity edema in patients with early ovarian cancerEpidemiology and treatment patterns of epithelial ovarian cancer.Cancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis.Cancer survival in Qidong between 1972 and 2011: A population-based analysis.Completeness of pedigree and family cancer history for ovarian cancer patientsAn increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosisThe prognostic value of CXCR4 in ovarian cancer: a meta-analysisDemethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway.Characteristics of Long-Term Survivors of Epithelial Ovarian CancerThe Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different: A Nationwide Population-Based Cohort Study.Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma.Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer.Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.Microarray expression profiling of long non-coding RNAs in epithelial ovarian cancer.Microarray analysis reveals differentially expressed lncRNAs in benign epithelial ovarian cysts and normal ovaries.Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator.Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic Malignancies.Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens.miR-214 targets the PTEN-mediated PI3K/Akt signaling pathway and regulates cell proliferation and apoptosis in ovarian cancer.Risks of female genital tract related cancers (gynecological cancers) or breast cancer in women with and without chronic kidney disease: A population-based cohort study in Taiwan.The clinical value of dynamic contrast-enhanced MRI in differential diagnosis of malignant and benign ovarian lesions.Prognostic factors in epithelial ovarian cancer: A population-based study.Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor
P2860
Q26859231-516DF104-7EF7-4702-BD53-1EA7EDC9799CQ30235358-E166D9F4-56FA-4D39-8645-CF5DC5924CD8Q30418500-244BD9DB-5D02-4720-9D4D-91DF9488FCA3Q33748254-34B85E05-F019-405E-81D5-4A985FEEFE5CQ34330356-DC31C76D-0A92-4146-BCDD-383F62C50D5CQ34558361-D048DC0B-A567-4267-9CC5-6FDEB7140FEEQ35127922-48961A93-A2D8-428D-A62D-4E1D77D5B466Q35820013-CD9E644E-E826-41B1-891C-37CB53A804AEQ35984294-8907CD19-8397-4BFE-964E-79557E188199Q36195795-0B1A6F22-B835-4F1A-85E0-6D6CDC234405Q36415295-D8EFF0E4-140F-4F78-A4BA-DB65F999B8F3Q36545468-4795026B-7D2E-4AAE-912B-2C80EF2BFEDDQ37092776-E124AB2A-4EDA-4161-89D4-3238F1179C64Q37709179-B60DDD60-E20E-4974-AD06-E7A5114F7D4DQ38388833-80A81ABC-87B7-40F1-BBB2-BB699D0807ECQ38430351-721E183A-E3B3-44F1-B233-ED496E53CE81Q38431931-839F64A2-7F23-481A-885C-33074C4F7402Q38844559-BE0D81F0-E1BF-439C-9DEF-7FFE80E19A98Q47094823-3F91AA1A-928C-49B3-A8CA-59AD5F072548Q47138082-A262E372-CBD4-4D11-AF99-9F531098F6BCQ47430029-CB8CF1D9-4E76-4DE5-9B8F-EC3C63940006Q52645239-B5F02EA8-79B1-4DC4-98AA-84D48523CED0Q53594556-E3BCE711-6B22-40B4-8AA3-6E9EFB97A427Q55315651-1A64D26B-4E05-4A5A-92AF-7E3805DA786BQ58779796-4921AC3E-3790-4B25-9AF6-874EB1E2F67E
P2860
Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan.
description
2013 թվականի հոկտեմբերի 2-ին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Trends in incidence and surviv ...... tion-based registry in Taiwan.
@en
Trends in incidence and surviv ...... tion-based registry in Taiwan.
@nl
type
label
Trends in incidence and surviv ...... tion-based registry in Taiwan.
@en
Trends in incidence and surviv ...... tion-based registry in Taiwan.
@nl
prefLabel
Trends in incidence and surviv ...... tion-based registry in Taiwan.
@en
Trends in incidence and surviv ...... tion-based registry in Taiwan.
@nl
P2093
P2860
P50
P1476
Trends in incidence and surviv ...... tion-based registry in Taiwan.
@en
P2093
Chun-Ju Chiang
Ming-Chieh Lin
Tsui-Hsia Hsu
Ying-Cheng Chiang
P2860
P304
P356
10.3802/JGO.2013.24.4.342
P577
2013-10-02T00:00:00Z